Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9Y2T4

Entry ID Method Resolution Chain Position Source
AF-Q9Y2T4-F1 Predicted AlphaFoldDB

221 variants for Q9Y2T4

Variant ID(s) Position Change Description Diseaes Association Provenance
rs747864353 1 M>? Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs768280067
CA2840346
2 G>A No ClinGen
ExAC
gnomAD
rs1194206870
CA356275431
7 T>A No ClinGen
gnomAD
rs1489153323
CA356275428
7 T>K No ClinGen
gnomAD
CA356275424
rs1289255132
8 R>W No ClinGen
gnomAD
rs949371849
CA92311367
15 L>V No ClinGen
TOPMed
gnomAD
CA356275358
rs1453652431
17 D>E No ClinGen
TOPMed
TCGA novel 17 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356275354
rs1401400042
18 H>Y No ClinGen
gnomAD
TCGA novel 22 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356187166
rs1263044518
26 I>V No ClinGen
TOPMed
gnomAD
rs1577129682
CA356187152
28 S>P No ClinGen
Ensembl
rs1009200231
CA91862583
29 T>A No ClinGen
Ensembl
CA356187142
rs1272579006
30 V>I No ClinGen
TOPMed
gnomAD
rs751114949
CA2840214
33 N>S No ClinGen
ExAC
gnomAD
CA91862570
rs1031902855
34 H>D No ClinGen
Ensembl
CA2840212
rs757810061
35 T>M No ClinGen
ExAC
gnomAD
TCGA novel 36 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2840209
rs761226047
37 E>D No ClinGen
ExAC
gnomAD
rs1389426870
CA356187078
40 A>T No ClinGen
gnomAD
CA356187054
rs1386974387
43 D>E No ClinGen
TOPMed
rs1169073410
CA356187037
46 G>S No ClinGen
TOPMed
gnomAD
CA91862552
rs904676187
47 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1577129554
CA356187025
48 V>G No ClinGen
Ensembl
CA356187028
rs1373942538
48 V>I No ClinGen
TOPMed
gnomAD
rs1032321120
CA91862541
49 V>I No ClinGen
TOPMed
gnomAD
TCGA novel 50 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1334918091
CA356187016
50 I>V No ClinGen
gnomAD
CA356186992
rs1214385056
53 R>Q No ClinGen
gnomAD
CA2840203
rs762909236
53 R>W No ClinGen
ExAC
gnomAD
CA2840202
rs775771834
54 E>Q No ClinGen
ExAC
gnomAD
rs1265972688
CA356186980
55 P>Q No ClinGen
TOPMed
CA356186951
rs201343301
57 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA91861069
rs375793522
57 S>T No ClinGen
Ensembl
CA2840171
rs781641771
58 K>Q No ClinGen
ExAC
gnomAD
CA356186930
rs202026671
60 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1257912436
CA356186933
60 A>S No ClinGen
gnomAD
CA2840170
rs202026671
60 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1283010592
CA356186893
65 G>V No ClinGen
gnomAD
rs200176027
CA91861062
66 E>K No ClinGen
1000Genomes
rs200481224
CA356186872
68 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs752918306
CA2840166
68 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs1355262542
CA356186870
69 V>M No ClinGen
gnomAD
rs1343939204
CA356186766
77 E>K No ClinGen
gnomAD
rs760729044
CA2840161
78 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA2840158
rs761614602
85 S>T No ClinGen
ExAC
gnomAD
CA356186603
rs1577126580
89 E>V No ClinGen
Ensembl
rs1305208352
CA356186596
90 E>K No ClinGen
gnomAD
CA2840156
rs768337204
103 A>P No ClinGen
ExAC
gnomAD
CA2840154
rs779671991
104 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA2840153
rs769193125
105 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA2840121
rs762760790
118 W>S No ClinGen
ExAC
gnomAD
CA2840120
rs775168990
121 T>S No ClinGen
ExAC
gnomAD
CA2840118
rs759067979
122 E>G No ClinGen
ExAC
gnomAD
rs1478956407
CA356186052
122 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA91859342
rs964976059
123 R>* No ClinGen
Ensembl
rs150954241
CA91859338
124 D>N No ClinGen
Ensembl
CA2840116
rs190838630
126 R>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA91859336
rs896915961
126 R>S No ClinGen
TOPMed
gnomAD
rs866322387
CA91859319
129 G>R No ClinGen
Ensembl
rs1031797235
CA91859299
136 E>Q No ClinGen
Ensembl
rs1341987148
CA356185877
137 G>R No ClinGen
TOPMed
TCGA novel 137 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356185820
rs1298604554
141 D>E No ClinGen
gnomAD
rs1372860491
CA356185822
141 D>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA2840109
rs139419142
142 L>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2840110
rs139419142
142 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2840107
rs763126722
144 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA2840105
rs764052676
146 T>M No ClinGen
ExAC
gnomAD
rs752487442
CA356185782
149 Q>E No ClinGen
ExAC
gnomAD
CA2840103
rs752487442
149 Q>K No ClinGen
ExAC
gnomAD
CA356185779
rs1404338076
149 Q>R No ClinGen
gnomAD
rs1036394073
CA91856459
156 M>V No ClinGen
TOPMed
TCGA novel 161 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356185434
rs1317972600
161 E>G No ClinGen
TOPMed
CA356185409
rs1385100274
163 S>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1459598988
CA356185345
170 N>S No ClinGen
gnomAD
rs1393273164
CA356185317
173 T>P No ClinGen
gnomAD
rs1165114993
CA356185308
174 Y>N No ClinGen
gnomAD
rs373814468
CA2840075
181 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2840073
rs150561015
185 C>Y No ClinGen
ESP
ExAC
rs1184521250
CA356185149
189 M>V No ClinGen
TOPMed
rs369585524
CA2840070
191 A>V No ClinGen
ESP
ExAC
gnomAD
TCGA novel 192 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1214496946
CA356185104
193 D>A No ClinGen
gnomAD
CA356185102
rs1214496946
193 D>G No ClinGen
gnomAD
CA356185093
rs1577119722
194 L>P No ClinGen
Ensembl
rs747980900
CA2840068
195 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2840067
rs778929388
195 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs1577119709
CA356185068
197 N>T No ClinGen
Ensembl
rs1577119699
CA356185039
200 H>P No ClinGen
Ensembl
CA356185024
rs1577119690
202 A>P No ClinGen
Ensembl
rs1577119678
CA356185005
204 T>P No ClinGen
Ensembl
CA356185001
rs1162516236
204 T>S No ClinGen
TOPMed
rs371827360
CA91827113
211 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
gnomAD
rs1247259830
CA356181734
214 K>N No ClinGen
TOPMed
gnomAD
rs1347846860
CA356181730
215 P>L No ClinGen
gnomAD
CA356181727
rs1239262134
216 A>T No ClinGen
gnomAD
CA2840040
rs765650812
217 N>H No ClinGen
ExAC
TOPMed
gnomAD
CA356181708
rs1354612897
218 M>I No ClinGen
gnomAD
rs1375368070
CA356181691
220 D>E No ClinGen
gnomAD
rs1456538721
CA356181684
221 L>R No ClinGen
TOPMed
CA91827100
rs916280657
222 T>M No ClinGen
gnomAD
rs1577090508
CA356181628
230 F>S No ClinGen
Ensembl
CA2840035
rs773263494
231 H>Q No ClinGen
ExAC
gnomAD
rs1185518267
CA356181607
233 H>P No ClinGen
TOPMed
gnomAD
rs1474880466
CA356181604
233 H>Q No ClinGen
TOPMed
gnomAD
rs1185518267
CA356181606
233 H>R No ClinGen
TOPMed
gnomAD
CA2840032
rs774545521
236 N>S No ClinGen
ExAC
gnomAD
CA356181583
rs774545521
236 N>T No ClinGen
ExAC
gnomAD
CA2840031
rs768473282
237 L>F No ClinGen
ExAC
gnomAD
CA2840029
rs775581608
239 V>I No ClinGen
ExAC
gnomAD
CA356181518
rs1560465955
245 G>D No ClinGen
Ensembl
CA356181510
rs1450767373
246 S>F No ClinGen
gnomAD
rs756994097
CA2840025
248 R>Q No ClinGen
ExAC
gnomAD
TCGA novel 251 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757919406
CA2840022
253 R>W No ClinGen
ExAC
gnomAD
TCGA novel 261 H>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356181406
rs1460745968
262 S>C No ClinGen
gnomAD
TCGA novel 262 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 264 L>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2840018
rs750844235
264 L>F No ClinGen
ExAC
gnomAD
CA356181395
rs750844235
264 L>I No ClinGen
ExAC
gnomAD
CA356180285
rs1577072836
270 D>A No ClinGen
Ensembl
CA356180264
rs1560449531
272 S>G No ClinGen
Ensembl
CA356180249
rs1370669801
272 S>R No ClinGen
TOPMed
rs1401064445
CA356180225
274 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA2839990
rs776449314
274 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs760422388
CA2839988
278 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs1426654793
CA356180150
279 E>D No ClinGen
gnomAD
CA2839985
rs747639231
284 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA356180053
rs1389741773
286 D>N No ClinGen
TOPMed
rs781570469
CA2839981
287 V>M No ClinGen
ExAC
gnomAD
CA356179934
rs1222177679
292 S>N No ClinGen
gnomAD
CA91811846
rs964415543
293 G>S No ClinGen
TOPMed
rs1268217098
CA356179891
294 R>C No ClinGen
gnomAD
rs868460193
CA91811839
294 R>L No ClinGen
Ensembl
rs1312118358
CA356179838
296 M>R No ClinGen
gnomAD
CA2839978
rs368801587
296 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA356179802
rs1360583500
298 T>A No ClinGen
gnomAD
TCGA novel 299 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs374362764
CA2839976
302 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
TCGA novel 310 N>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA356179457
rs1201663134
313 A>T No ClinGen
TOPMed
CA356179444
rs1183543693
314 R>G No ClinGen
gnomAD
CA91811745
rs531829023
314 R>K No ClinGen
1000Genomes
TOPMed
rs753771610
CA2839973
316 I>T No ClinGen
ExAC
gnomAD
CA356179406
rs1473897058
316 I>V No ClinGen
gnomAD
TCGA novel 317 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs762501712
CA2839945
323 D>G No ClinGen
ExAC
gnomAD
rs763692349
CA2839946
323 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA356178110
rs1190542476
324 Y>S No ClinGen
gnomAD
CA2839944
rs374272092
326 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs773880296
CA2839941
334 E>D No ClinGen
ExAC
gnomAD
CA2839939
rs748566105
336 D>H No ClinGen
ExAC
gnomAD
CA2839937
rs755209779
340 D>E No ClinGen
ExAC
gnomAD
rs749379375
CA2839936
341 K>T No ClinGen
ExAC
gnomAD
CA356177831
rs1168119647
344 C>S No ClinGen
TOPMed
rs779928185
CA2839935
345 A>S No ClinGen
ExAC
gnomAD
CA2839933
rs267600204
348 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA356177743
rs757014009
349 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA356177730
rs1429541816
350 D>G No ClinGen
gnomAD
CA356177737
rs1453968502
350 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA2839905
rs762339661
352 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA91801298
rs948636545
353 I>V No ClinGen
TOPMed
rs768851640
CA2839903
357 A>T No ClinGen
ExAC
gnomAD
CA2839902
rs763404513
363 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2839901
rs775542255
365 F>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs770049137
CA2839900
366 D>N No ClinGen
ExAC
gnomAD
CA2839899
rs367696094
367 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
rs1204594682
CA356176021
367 R>W No ClinGen
TOPMed
rs1577063114
CA356175994
369 T>P No ClinGen
Ensembl
rs781182513
CA2839898
371 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA356175956
rs1340045766
371 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA356175925
rs1158595049
373 V>M No ClinGen
gnomAD
rs1577063066
CA356175912
374 T>P No ClinGen
Ensembl
CA356175853
rs1242711583
378 S>* No ClinGen
TOPMed
rs1242711583
CA356175850
378 S>L No ClinGen
TOPMed
rs752589937
CA2839893
379 R>K No ClinGen
ExAC
gnomAD
rs754747800
CA2839891
380 E>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs753541104
CA2839890
381 S>G No ClinGen
ExAC
gnomAD
CA91801136
rs1048743697
383 K>E No ClinGen
Ensembl
rs765926966
CA2839889
384 P>L No ClinGen
ExAC
gnomAD
rs1444984786
CA356175769
384 P>S No ClinGen
gnomAD
CA356175763
rs1330379905
385 R>Q No ClinGen
TOPMed
gnomAD
CA2839888
rs760251644
385 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA356175758
rs1270601018
386 A>P No ClinGen
gnomAD
rs1175331044
CA356175727
391 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA2839886
rs750077410
391 R>W Variant assessed as Somatic; 9.26e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA2839885
rs763204097
392 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA356175722
rs1403427226
392 R>H No ClinGen
TOPMed
rs1363348655
CA356175710
394 C>Y No ClinGen
gnomAD
CA2839882
rs375066274
395 V>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2839881
rs375066274
395 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA356175700
rs1162714277
396 G>R No ClinGen
TOPMed
gnomAD
CA2839880
rs770960380
397 G>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA356175680
rs1164835896
399 R>C No ClinGen
gnomAD
CA2839878
rs200809882
399 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs747148764
CA91801028
400 R>Q No ClinGen
TOPMed
gnomAD
rs778779009
CA2839875
400 R>W No ClinGen
ExAC
gnomAD
rs754837498
CA2839874
401 R>C No ClinGen
ExAC
gnomAD
rs748903409
CA2839873
401 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs754837498
CA356175674
401 R>S No ClinGen
ExAC
gnomAD
rs1214417537
CA356175661
403 D>H No ClinGen
TOPMed
CA356175653
rs1467691614
404 I>V No ClinGen
gnomAD
CA356175584
rs1270935998
413 K>R No ClinGen
TOPMed
CA2839869
rs371740090
418 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA91800940
rs897978474
422 P>S No ClinGen
TOPMed
TCGA novel 425 N>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs3796403
CA356175459
429 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs545674626
CA91800915
429 I>T No ClinGen
1000Genomes
rs1427606304
CA356175456
430 A>T No ClinGen
TOPMed
gnomAD
rs759923972
CA2839865
431 A>T No ClinGen
ExAC
gnomAD
CA91800886
rs969324820
437 I>V No ClinGen
Ensembl
rs776801658
CA2839864
439 Q>* No ClinGen
ExAC
gnomAD
CA91800881
rs1022279531
442 V>A No ClinGen
TOPMed
gnomAD
rs1392708055
CA356175372
442 V>I No ClinGen
gnomAD
rs766669913
CA2839863
443 N>D No ClinGen
ExAC
gnomAD
CA2839861
rs760655172
446 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs1350113609
CA356175331
447 H>Q No ClinGen
TOPMed
rs1450253169
CA356175336
447 H>Y No ClinGen
gnomAD

No associated diseases with Q9Y2T4

8 regional properties for Q9Y2T4

Type Name Position InterPro Accession
repeat WD40 repeat 13 - 52 IPR001680-1
repeat WD40 repeat 79 - 119 IPR001680-2
repeat WD40 repeat 161 - 200 IPR001680-3
repeat WD40 repeat 211 - 251 IPR001680-4
repeat WD40 repeat 270 - 308 IPR001680-5
repeat WD40 repeat 402 - 439 IPR001680-6
conserved_site Protein phosphatase 2A regulatory subunit PR55, conserved site 79 - 93 IPR018067-1
conserved_site Protein phosphatase 2A regulatory subunit PR55, conserved site 170 - 184 IPR018067-2

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
protein phosphatase type 2A complex A protein complex that has protein serine/threonine phosphatase activity that is polycation-stimulated (PCS), being directly stimulated by protamine, polylysine, or histone H1; it constitutes a subclass of several enzymes activated by different histones and polylysine, and consists of catalytic, scaffolding, and regulatory subunits. The catalytic and scaffolding subunits form the core enzyme, and the holoenzyme also includes the regulatory subunit.

1 GO annotations of molecular function

Name Definition
protein phosphatase regulator activity Binds to and modulates the activity of a protein phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a protein substrate molecule.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

15 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5E9Q7 PPP2R2B Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Bos taurus (Bovine) PR
Q5ZIY5 PPP2R2D Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform Gallus gallus (Chicken) PR
Q00005 PPP2R2B Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Homo sapiens (Human) PR
Q66LE6 PPP2R2D Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform Homo sapiens (Human) PR
Q6P1F6 Ppp2r2a Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform Mus musculus (Mouse) PR
Q6ZWR4 Ppp2r2b Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Mus musculus (Mouse) PR
Q8BG02 Ppp2r2c Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform Mus musculus (Mouse) PR
P54614 PPP2R2B Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Sus scrofa (Pig) PR
P36877 Ppp2r2b Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Rattus norvegicus (Rat) PR
P97888 Ppp2r2c Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform Rattus norvegicus (Rat) PR
Q0E2P1 Os02g0224200 Serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Oryza sativa subsp japonica (Rice) PR
Q38821 PP2AB1 Serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform Arabidopsis thaliana (Mouse-ear cress) PR
Q0D2F4 ppp2r2b Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q6DIY3 ppp2r2d Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q6NY64 ppp2r2d Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MGEDTDTRKI NHSFLRDHSY VTEADIISTV EFNHTGELLA TGDKGGRVVI FQREPESKNA
70 80 90 100 110 120
PHSQGEYDVY STFQSHEPEF DYLKSLEIEE KINKIKWLPQ QNAAHSLLST NDKTIKLWKI
130 140 150 160 170 180
TERDKRPEGY NLKDEEGKLK DLSTVTSLQV PVLKPMDLMV EVSPRRIFAN GHTYHINSIS
190 200 210 220 230 240
VNSDCETYMS ADDLRINLWH LAITDRSFNI VDIKPANMED LTEVITASEF HPHHCNLFVY
250 260 270 280 290 300
SSSKGSLRLC DMRAAALCDK HSKLFEEPED PSNRSFFSEI ISSVSDVKFS HSGRYMLTRD
310 320 330 340 350 360
YLTVKVWDLN MEARPIETYQ VHDYLRSKLC SLYENDCIFD KFECAWNGSD SVIMTGAYNN
370 380 390 400 410 420
FFRMFDRNTK RDVTLEASRE SSKPRAVLKP RRVCVGGKRR RDDISVDSLD FTKKILHTAW
430 440
HPAENIIAIA ATNNLYIFQD KVNSDMH